ALGM vs IPGP

ALGM's deterministic health scores signal significant financial distress: the Piotroski F-Score of 2/9 indicates weak operational and financial health, while the absence of an Altman Z-Score raises concerns about bankruptcy risk. Despite strong revenue growth (28.9% YoY) and positive earnings momentum (114.3% YoY EPS growth), the company reports negative profit margins (-1.57%) and ROE (-1.36%), undermining profitability sustainability. Insider selling totaling $1.65M over six months and a bearish technical trend further erode confidence. The stock trades at a premium valuation (Forward P/E: 33.05, Price/Sales: 6.87) relative to its weak fundamentals, suggesting overvaluation.

IPGP exhibits a stable but mediocre Piotroski F-Score of 4/9, indicating a lack of strong fundamental momentum despite a pristine balance sheet. The stock is trading at a massive premium, with a current price of $127.32 far exceeding both the Graham Number ($28.81) and the Intrinsic Value ($21.54). While earnings growth is accelerating and debt is negligible, the astronomical P/E ratio of 174.41 and heavy insider selling suggest the current valuation is unsustainable. The disconnect between the deterministic value scores and the market price creates a high-risk profile.